Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Experimental serogroup B meningococcal vaccines have induced only poor immune responses and have had little protective efficacy in children younger than 1 year of age. We used ELISA with potassium thiocyanate to compare the average avidity of antibody produced by infants with that of children older...

Descripció completa

Dades bibliogràfiques
Autors principals:	Pollard, A, Levin, M
Format:	Journal article
Idioma:	English
Publicat:	2000

Ítems similars

Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
per: C.A.C. Gioia, et al.

Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine Against Genetically Diverse Serogroup B Meningococci
per: Giuntini, S, et al.
Publicat: (2016)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
per: Cecilia Fazio, et al.
Publicat: (2021-07-01)

Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
per: Paola Stefanelli, et al.
Publicat: (2017-05-01)

Serogroup C meningococci in Italy in the era of conjugate menC vaccination
per: Neri Arianna, et al.
Publicat: (2009-08-01)

Cluster of Serogroup W135 Meningococci, Southeastern Florida, 2008–2009
per: Timothy J. Doyle, et al.
Publicat: (2010-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
per: Alessandra Lo Presti, et al.
Publicat: (2023-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
per: Alessandra Lo Presti, et al.
Publicat: (2023-01-01)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
per: Pollard, A, et al.
Publicat: (2004)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.
per: Pollard, A, et al.
Publicat: (2004)

Distribution of Serogroups of Neisseria meningitidis and Antigenic Characterization of Serogroup Y Meningococci in Canada, January 1, 1999 to June 30, 2001
per: Raymond SW Tsang, et al.
Publicat: (2002-01-01)

Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America
per: Andrew J. Pollard, et al.
Publicat: (2004-10-01)

Frequent capsule switching in 'ultra-virulent' meningococci - are we ready for a serogroup B ST-11 complex outbreak?
per: Lucidarme, J, et al.
Publicat: (2017)

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
per: Ibarz-Pavón, AB, et al.
Publicat: (2011)

Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation
per: Ibarz-Pavon, AB, et al.
Publicat: (2011)

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
per: Samy Taha, et al.
Publicat: (2022-06-01)

Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.
per: Christopher B Sullivan, et al.
Publicat: (2015-01-01)

Opa protein repertoires of disease-causing and carried meningococci
per: Callaghan, M, et al.
Publicat: (2008)

Opa protein repertoires of disease-causing and carried meningococci
per: Callaghan, M, et al.
Publicat: (2008)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
per: Emil Kupek, et al.

Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines.
Publicat: (2015-01-01)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
per: Kupek Emil, et al.
Publicat: (2001-01-01)

Age dependence of in vitro survival of meningococci in whole blood during childhood.
per: Ison, C, et al.
Publicat: (2003)

Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
per: Kelly, D, et al.
Publicat: (2009)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
per: Aapo Knuutila, et al.
Publicat: (2023-12-01)

Invasive infections due to group a streptococci and meningococci
per: Jesús Ruiz-Contreras
Publicat: (2019-11-01)

The beginning of the end for serogroup B meningococcus?
per: Snape, MD, et al.
Publicat: (2013)

The beginning of the end for serogroup B meningococcus?
per: Snape, MD, et al.
Publicat: (2013)

Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
per: Bårnes, G, et al.
Publicat: (2011)

Serogroup B meningococcal vaccines-an unfinished story.
per: Sadarangani, M, et al.
Publicat: (2010)

Clinical and economic estimation of children’s pharmacotherapy with meningococcial infections in Ukraine
per: Iryna Bilyk, et al.
Publicat: (2019-12-01)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
per: Snape, M, et al.
Publicat: (2013)

Penicillin Dalam Pengobatan Infeksi Meningococci
per: Perpustakaan UGM, i-lib
Publicat: (1974)

Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
per: Callaghan, M, et al.
Publicat: (2011)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
per: Snape, MD, et al.
Publicat: (2013)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
per: Li, K, et al.
Publicat: (2023)

Towards an improved serogroup B Neisseria meningitidis vaccine.
per: Perrett, K, et al.
Publicat: (2005)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
per: Jonathon M. Monroe, et al.
Publicat: (2022-11-01)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
per: Snape, M, et al.
Publicat: (2015)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
per: Kan Li, et al.
Publicat: (2023-02-01)